Cerevel Therapeutics
222 Jacobs Street,
Cambridge, 2141, MA,
United States
Cambridge, 2141, MA,
United States
1 800-674-3612
Life Sciences
Cerevel Therapeutics Technographics
Cerevel Therapeutics Technographics, Software Purchases, AI and Digital Transformation Initiatives
Discover the latest software purchases and digital transformation initiatives being undertaken by Cerevel Therapeutics and its business and technology executives. Each quarter our research team identifies on-prem and cloud applications that are being used by the 200 Cerevel Therapeutics employees from the public (Press Releases, Customer References, Testimonials, Case Studies and Success Stories) and proprietary sources.
During our research, we have identified that Cerevel Therapeutics has purchased the following applications: Veeva Vault Training for Learning and Development in 2023, DocuSign eSignature for Digital Signing in 2021, New Relic APM for Application Performance Management in 2021 and the related IT decision-makers and key stakeholders.
Our database provides customer insight and contextual information on which enterprise applications and software systems Cerevel Therapeutics is running and its propensity to invest more and deepen its relationship with Veeva Systems , DocuSign , New Relic or identify new suppliers as part of their overall Digital and IT transformation projects to stay competitive, fend off threats from disruptive forces, or comply with internal mandates to improve overall enterprise efficiency.
We have been analyzing Cerevel Therapeutics revenues, which have grown to $20.0 million in 2024, plus its IT budget and roadmap, cloud software purchases, aggregating massive amounts of data points that form the basis of our forecast assumptions for Cerevel Therapeutics intention to invest in emerging technologies such as AI, Machine Learning, IoT, Blockchain, Autonomous Database or in cloud-based ERP, HCM, CRM, EPM, Procurement or Treasury applications.
Cerevel Therapeutics Tech Stack and Enterprise Applications
Cerevel Therapeutics HCM
Vendor |
Previous System |
Application |
Category |
Market |
VAR/SI |
When |
Live |
Insight |
|---|---|---|---|---|---|---|---|---|
| Veeva Systems | Legacy | Veeva Vault Training | Learning and Development | HCM | n/a | 2023 | 2023 |
In 2023, Cerevel Therapeutics implemented Veeva Vault Training to centralize GxP learning and employee qualification workflows. The deployment targeted Learning and Development as the primary application category, positioning Veeva Vault Training as the core system for designing and administering validated training programs across quality and operations functions.
Veeva Vault Training was configured to support end-to-end training programs, including content management, accredited eLearning course delivery, assignment rules, and learner progress tracking. The implementation emphasized validated GxP workflows and training qualification processes so that assignments, competency gates, and completion records are managed within the Veeva Vault Training application.
The deployment integrated with Veeva Vault QualityDocs and Veeva LearnGxP to link controlled documentation, standard operating procedures, and accredited course content with training assignments and records. The solution was provisioned as a validated cloud-based training platform, used by quality operations and quality assurance teams to streamline onboarding and ongoing employee qualification activities.
Governance focused on centralized assignment logic, audit-ready training records, and role-based visibility to support inspection readiness and compliance workflows. Cerevel’s quality operations manager reported that using Veeva Vault Training and Veeva LearnGxP improved compliance and operational efficiency, enabling the company to manage training, assign courses, and track progress from a single Learning and Development system.
|
|
|
|
|
Learning and Development | HCM |
|
2023 | 2023 |
|
Cerevel Therapeutics Content Management
Vendor |
Previous System |
Application |
Category |
Market |
VAR/SI |
When |
Live |
Insight |
|---|---|---|---|---|---|---|---|---|
| DocuSign | Legacy | DocuSign eSignature | Digital Signing | Content Management | n/a | 2021 | 2021 |
In 2021, Cerevel Therapeutics implemented DocuSign eSignature as a Digital Signing solution on its public website. The deployment embeds DocuSign eSignature to capture authenticated electronic signatures and to orchestrate web-based document signing workflows for external stakeholders.
Implementation focused on embedding DocuSign eSignature signing envelopes and signature fields within website pages, leveraging standard eSignature capabilities such as recipient authentication options, signing ceremonies, and audit trail capture. Operational scope emphasizes external document execution and consent capture tied to corporate processes, with functional impact on contract execution and web form processing. Governance centers on preserving auditability and records retention for electronic signatures, with configuration attention to secure transmission, recipient routing, and session continuity for web-originated transactions.
|
Cerevel Therapeutics ITSM
Vendor |
Previous System |
Application |
Category |
Market |
VAR/SI |
When |
Live |
Insight |
|---|---|---|---|---|---|---|---|---|
| New Relic | Legacy | New Relic APM | Application Performance Management | ITSM | n/a | 2021 | 2021 |
In 2021, Cerevel Therapeutics deployed New Relic APM for Application Performance Management on their website to establish continuous observability of web application performance. New Relic APM was instrumented to capture server-side transaction traces and browser real user monitoring across the public site, enabling application-level telemetry collection and centralized dashboards.
Configuration focused on core APM capabilities typical for Application Performance Management, including transaction tracing, error and exception analytics, response time breakdowns, and alerting rules tied to performance thresholds. The deployment included dashboarding and alert workflows to surface slow transactions and application errors, and the New Relic APM installation was used to standardize monitoring across the customer-facing web stack.
Operational ownership centered on engineering and IT operations for incident detection and triage, with the scope explicitly limited to the company website. Governance emphasized centralized performance visibility and coordinated alert handling, aligning monitoring outputs with engineering runbooks and support procedures to accelerate troubleshooting for web application issues.
|
Cerevel Therapeutics IaaS
Vendor |
Previous System |
Application |
Category |
Market |
VAR/SI |
When |
Live |
Insight |
|---|---|---|---|---|---|---|---|---|
|
|
|
|
Application Hosting and Computing Services | IaaS |
|
2020 | 2020 |
|
Cerevel Therapeutics CyberSecurity
Vendor |
Previous System |
Application |
Category |
Market |
VAR/SI |
When |
Live |
Insight |
|---|---|---|---|---|---|---|---|---|
|
|
|
|
Secure Email Gateways (SEGs) | CyberSecurity |
|
2019 | 2019 |
|
IT Decision Makers and Key Stakeholders at Cerevel Therapeutics
| First Name | Last Name | Title | Function | Department | Phone | |
|---|---|---|---|---|---|---|
| No data found | ||||||
Apps Being Evaluated by Cerevel Therapeutics Executives
APPS RUN THE WORLD tracks software evaluation trends across 2 million companies worldwide, including buyer insights from Cerevel Therapeutics IT executives and key decision makers. As part of ARTW Buyer Intent and technographics insights, these findings provide useful visibility into the Cerevel Therapeutics digital transformation priorities and AI adoption trends.
| Date | Company | Status | Vendor | Product | Category | Market |
|---|---|---|---|---|---|---|
| No data found | ||||||
FAQ - APPS RUN THE WORLD Cerevel Therapeutics Technographics
Cerevel Therapeutics is a Life Sciences organization based in United States,
with around 200 employees and annual revenues of $20.0 million.
Cerevel Therapeutics operates a diverse technology stack with applications such as
Veeva Vault Training, DocuSign eSignature and New Relic APM,
covering areas like Learning and Development, Digital Signing and Application Performance Management.
Cerevel Therapeutics has invested in cloud applications and AI-driven platforms to optimize efficiency and growth,
collaborating with vendors such as Veeva Systems, DocuSign and New Relic.
Cerevel Therapeutics recently adopted applications including
Veeva Vault Training in 2023, Veeva LearnGxP in 2023 and DocuSign eSignature in 2021,
highlighting its ongoing modernization strategy.
APPS RUN THE WORLD maintains an up-to-date database of Cerevel Therapeutics’s key decision makers and IT executives,
available to Premium subscribers.
Our research team continuously updates Cerevel Therapeutics’s profile with verified software purchases,
vendor relationships, and digital initiatives identified from public and proprietary sources.
Subscribe to APPS RUN THE WORLD to access the complete Cerevel Therapeutics technographics profile,
including detailed breakdowns by category, vendor, and IT decision makers.